2023 annual financial data
Assembly Biosciences 2023 Operating margin
Assembly Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was -902.5%.
Operating income was -64,646,000 USD and net income was -61,228,000 USD.
Operating cash flow was 22,743,000 USD.
Get free Assembly Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,163,000 USD
- Operating income
- -64,646,000 USD
- Net income
- -61,228,000 USD
- Operating cash flow
- 22,743,000 USD